Regulation mechanism of Fbxw7-related signaling pathways (Review)

Zhenyu Zhou1, Chuanchao He1, Jie Wang1

  • 1Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510120, P.R. China.

Oncology Reports
|September 2, 2015
PubMed

Insights

F-box and WD repeat domain-containing 7 (Fbxw7) acts as a tumor suppressor by regulating cyclin E and c-Myc. Understanding Fbxw7 regulation is key to its role in hepatocellular carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • F-box and WD repeat domain-containing 7 (Fbxw7) is a tumor suppressor regulating cell growth and survival.
  • Key Fbxw7 substrates include cyclin E and c-Myc, crucial in cell cycle and proliferation.
  • Dysregulation of Fbxw7 pathways is implicated in hepatocellular carcinoma development.

Purpose of the Study:

  • To review the regulatory mechanisms of Fbxw7/cyclin E and Fbxw7/c-Myc pathways.
  • To elucidate the role of Fbxw7 in hepatocellular carcinoma.
  • To provide insights into potential therapeutic strategies targeting Fbxw7.

Main Methods:

  • Literature review of studies on Fbxw7, cyclin E, and c-Myc.
  • Analysis of regulatory networks involving Fbxw7 substrates.
  • Synthesis of current knowledge on Fbxw7 in hepatocellular carcinoma.

Main Results:

  • Fbxw7's tumor-suppressive function is mediated through the degradation of key oncoproteins like cyclin E and c-Myc.
  • Multiple regulators fine-tune the activity of Fbxw7/cyclin E and Fbxw7/c-Myc pathways.
  • Aberrant Fbxw7 activity is frequently observed in hepatocellular carcinoma.

Conclusions:

  • Fbxw7 plays a critical role in suppressing hepatocellular carcinoma through its control of cyclin E and c-Myc.
  • Understanding the complex regulation of Fbxw7 pathways is essential for comprehending its tumor-suppressive functions.
  • Targeting Fbxw7 pathways may offer novel therapeutic avenues for hepatocellular carcinoma treatment.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
11.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

2.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

1.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K